ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,08985
-0,01%
Bitcoin
64.433,16
-0,65%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
13/05/200423h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Banc of America Health Care ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/05/200423h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces results for the first quarter ended March 31, 2004NASDAQ:ANPI
03/05/200423h05PR Newswire (US)Angiotech to webcast conference call discussing first quarter 2004 financial resultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
27/04/200423h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Deutsche Bank Health Care ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/04/200415h00PR Newswire (US)Angiotech extends exclusive licensing agreement with Poly-Med for biomaterial technologiesNASDAQ:ANPI
31/03/200419h10PR Newswire (US)Angiotech partner concludes enrollment in TAXUS V clinical trialNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/03/200414h00PR Newswire (US)Angiotech licenses technology from The University of British ColumbiaNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/03/200422h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces results for the quarter and year ended December 31, 2003NASDAQ:ANPI
09/03/200422h36PR Newswire (US)Angiotech to webcast conference call discussing year end 2003 financial resultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/03/200423h54PR Newswire (US)Angiotech Partner announces FDA approval for its TAXUS(TM) Express2(TM) paclitaxel-eluting coronary stent systemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/02/200422h05PR Newswire (US)Angiotech Pharmaceuticals to Participate in Lehman Brothers Global Healthcare ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/02/200415h34PR Newswire (US)MORNING UPDATE: Man Securities Issues Alerts for EMC, SLR, TJX, ANPI, and HRBNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/01/200414h00PR Newswire (US)Fairvest recommends shareholders vote in favor of Angiotech's new stock option plan & share splitNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
07/01/200422h20PR Newswire (US)Angiotech Pharmaceuticals to participate in JP Morgan Healthcare ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/12/200319h53PR Newswire (US)Angiotech completes acquisition of STS BiopolymersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/12/200314h00PR Newswire (US)Angiotech Pharmaceuticals Inc. proposes stock splitNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/11/200323h27PR Newswire (US)Angiotech completes enrollment for Phase 2 clinical study in rheumatoid arthritisNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/11/200323h11PR Newswire (US)Angiotech announces termination of license arrangementNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/11/200302h00PR Newswire (US)Angiotech corporate partner announces court decision denying preliminary injunctions on drug eluting stentsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
20/11/200323h16PR Newswire (US)FDA panel recommends approval for Angiotech partner Boston Scientific's TAXUS(TM) Express2(TM) paclitaxel-eluting coronary stentNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
20/11/200314h03PR Newswire (US)Angiotech trading halt pending FDA Panel MeetingNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
18/11/200303h57PR Newswire (US)Angiotech issues clarification on fourth quarter conference callNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/11/200322h02PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces results for the fourth quarter ended September 30, 2003NASDAQ:ANPI
14/11/200314h47PR Newswire (US)Angiotech announces agreement to acquire STS Biopolymers, Inc.NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/11/200322h05PR Newswire (US)Angiotech to webcast conference call discussing fourth quarter 2003 financial resultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/11/200321h15PR Newswire (US)Angiotech partner, Boston Scientific announces 12-month follow-up data from Taxus IV clinical trialNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

FX
EURUSD
Euro vs US Dollar
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
CCOM
US100
US Tech 100
AMEX
SPY
SPDR S&P 500
DBI
DAX
DAX
TG
CBK
Commerzbank
TG
BAYN
Bayer
TG
432
Arbor Metals
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten